U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Pharyngolaryngeal Pain

MedGen UID:
163560
•Concept ID:
C0858635
•
Sign or Symptom

Definition

Painful sensation in the pharyngolaryngeal region. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVPharyngolaryngeal Pain

Professional guidelines

PubMed

Practical considerations in the management of inhaled prostacyclin therapy for pulmonary hypertension associated with interstitial lung disease (WHO group 3).
Lee C, Hamlyn J, Porcelli J, Schmit A
Respir Med 2022 May;196:106806. Epub 2022 Mar 12 doi: 10.1016/j.rmed.2022.106806. PMID: 35334313
The use of inhaled mannitol in the diagnosis and management of asthma.
Sverrild A, Porsbjerg C, Backer V
Expert Opin Pharmacother 2012 Jan;13(1):115-23. Epub 2011 Nov 26 doi: 10.1517/14656566.2012.638917. PMID: 22118547
Sapropterin: a review of its use in the treatment of primary hyperphenylalaninaemia.
Sanford M, Keating GM
Drugs 2009;69(4):461-76. doi: 10.2165/00003495-200969040-00006. PMID: 19323589

Recent clinical studies

Etiology

Practical considerations in the management of inhaled prostacyclin therapy for pulmonary hypertension associated with interstitial lung disease (WHO group 3).
Lee C, Hamlyn J, Porcelli J, Schmit A
Respir Med 2022 May;196:106806. Epub 2022 Mar 12 doi: 10.1016/j.rmed.2022.106806. PMID: 35334313
Inhaled mannitol for cystic fibrosis.
Nevitt SJ, Thornton J, Murray CS, Dwyer T
Cochrane Database Syst Rev 2018 Feb 9;2(2):CD008649. doi: 10.1002/14651858.CD008649.pub3. PMID: 29424930Free PMC Article
Inhaled mannitol for cystic fibrosis.
Nolan SJ, Thornton J, Murray CS, Dwyer T
Cochrane Database Syst Rev 2015 Oct 9;(10):CD008649. doi: 10.1002/14651858.CD008649.pub2. PMID: 26451533
Rituximab for relapsing-remitting multiple sclerosis.
He D, Guo R, Zhang F, Zhang C, Dong S, Zhou H
Cochrane Database Syst Rev 2013 Dec 6;(12):CD009130. doi: 10.1002/14651858.CD009130.pub3. PMID: 24310855
Sapropterin: a review of its use in the treatment of primary hyperphenylalaninaemia.
Sanford M, Keating GM
Drugs 2009;69(4):461-76. doi: 10.2165/00003495-200969040-00006. PMID: 19323589

Diagnosis

The use of inhaled mannitol in the diagnosis and management of asthma.
Sverrild A, Porsbjerg C, Backer V
Expert Opin Pharmacother 2012 Jan;13(1):115-23. Epub 2011 Nov 26 doi: 10.1517/14656566.2012.638917. PMID: 22118547
Do formulation switches exacerbate existing medical illness? Results of an open-label transition to orally disintegrating risperidone tablets.
Chue P, Prinzo RS, Binder CE
Hum Psychopharmacol 2007 Jul;22(5):307-14. doi: 10.1002/hup.852. PMID: 17487933
The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) saline.
Brannan JD, Anderson SD, Perry CP, Freed-Martens R, Lassig AR, Charlton B; Aridol Study Group
Respir Res 2005 Dec 9;6(1):144. doi: 10.1186/1465-9921-6-144. PMID: 16336673Free PMC Article

Therapy

Practical considerations in the management of inhaled prostacyclin therapy for pulmonary hypertension associated with interstitial lung disease (WHO group 3).
Lee C, Hamlyn J, Porcelli J, Schmit A
Respir Med 2022 May;196:106806. Epub 2022 Mar 12 doi: 10.1016/j.rmed.2022.106806. PMID: 35334313
Inhaled mannitol for cystic fibrosis.
Nevitt SJ, Thornton J, Murray CS, Dwyer T
Cochrane Database Syst Rev 2018 Feb 9;2(2):CD008649. doi: 10.1002/14651858.CD008649.pub3. PMID: 29424930Free PMC Article
Inhaled mannitol for cystic fibrosis.
Nolan SJ, Thornton J, Murray CS, Dwyer T
Cochrane Database Syst Rev 2015 Oct 9;(10):CD008649. doi: 10.1002/14651858.CD008649.pub2. PMID: 26451533
The use of inhaled mannitol in the diagnosis and management of asthma.
Sverrild A, Porsbjerg C, Backer V
Expert Opin Pharmacother 2012 Jan;13(1):115-23. Epub 2011 Nov 26 doi: 10.1517/14656566.2012.638917. PMID: 22118547
Sapropterin: a review of its use in the treatment of primary hyperphenylalaninaemia.
Sanford M, Keating GM
Drugs 2009;69(4):461-76. doi: 10.2165/00003495-200969040-00006. PMID: 19323589

Prognosis

Inhaled mannitol for cystic fibrosis.
Nevitt SJ, Thornton J, Murray CS, Dwyer T
Cochrane Database Syst Rev 2020 May 1;5(5):CD008649. doi: 10.1002/14651858.CD008649.pub4. PMID: 32358807Free PMC Article
Inhaled mannitol for cystic fibrosis.
Nevitt SJ, Thornton J, Murray CS, Dwyer T
Cochrane Database Syst Rev 2018 Feb 9;2(2):CD008649. doi: 10.1002/14651858.CD008649.pub3. PMID: 29424930Free PMC Article
Inhaled mannitol for cystic fibrosis.
Nolan SJ, Thornton J, Murray CS, Dwyer T
Cochrane Database Syst Rev 2015 Oct 9;(10):CD008649. doi: 10.1002/14651858.CD008649.pub2. PMID: 26451533
Rituximab for relapsing-remitting multiple sclerosis.
He D, Guo R, Zhang F, Zhang C, Dong S, Zhou H
Cochrane Database Syst Rev 2013 Dec 6;(12):CD009130. doi: 10.1002/14651858.CD009130.pub3. PMID: 24310855
The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) saline.
Brannan JD, Anderson SD, Perry CP, Freed-Martens R, Lassig AR, Charlton B; Aridol Study Group
Respir Res 2005 Dec 9;6(1):144. doi: 10.1186/1465-9921-6-144. PMID: 16336673Free PMC Article

Clinical prediction guides

Inhaled mannitol for cystic fibrosis.
Nevitt SJ, Thornton J, Murray CS, Dwyer T
Cochrane Database Syst Rev 2020 May 1;5(5):CD008649. doi: 10.1002/14651858.CD008649.pub4. PMID: 32358807Free PMC Article
Inhaled mannitol for cystic fibrosis.
Nevitt SJ, Thornton J, Murray CS, Dwyer T
Cochrane Database Syst Rev 2018 Feb 9;2(2):CD008649. doi: 10.1002/14651858.CD008649.pub3. PMID: 29424930Free PMC Article
Inhaled mannitol for cystic fibrosis.
Nolan SJ, Thornton J, Murray CS, Dwyer T
Cochrane Database Syst Rev 2015 Oct 9;(10):CD008649. doi: 10.1002/14651858.CD008649.pub2. PMID: 26451533
Rituximab for relapsing-remitting multiple sclerosis.
He D, Guo R, Zhang F, Zhang C, Dong S, Zhou H
Cochrane Database Syst Rev 2013 Dec 6;(12):CD009130. doi: 10.1002/14651858.CD009130.pub3. PMID: 24310855
Sapropterin: a review of its use in the treatment of primary hyperphenylalaninaemia.
Sanford M, Keating GM
Drugs 2009;69(4):461-76. doi: 10.2165/00003495-200969040-00006. PMID: 19323589

Recent systematic reviews

Inhaled mannitol for cystic fibrosis.
Nevitt SJ, Thornton J, Murray CS, Dwyer T
Cochrane Database Syst Rev 2020 May 1;5(5):CD008649. doi: 10.1002/14651858.CD008649.pub4. PMID: 32358807Free PMC Article
Inhaled mannitol for cystic fibrosis.
Nevitt SJ, Thornton J, Murray CS, Dwyer T
Cochrane Database Syst Rev 2018 Feb 9;2(2):CD008649. doi: 10.1002/14651858.CD008649.pub3. PMID: 29424930Free PMC Article
Inhaled mannitol for cystic fibrosis.
Nolan SJ, Thornton J, Murray CS, Dwyer T
Cochrane Database Syst Rev 2015 Oct 9;(10):CD008649. doi: 10.1002/14651858.CD008649.pub2. PMID: 26451533
Rituximab for relapsing-remitting multiple sclerosis.
He D, Guo R, Zhang F, Zhang C, Dong S, Zhou H
Cochrane Database Syst Rev 2013 Dec 6;(12):CD009130. doi: 10.1002/14651858.CD009130.pub3. PMID: 24310855

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...